Quality assurance news and resources ǀ Inglasia Pharma Solutions

Showing posts 1-6 of 131

What Happens After a GDP Audit? Managing Findings, CAPA and Remediation

Receiving the final report after a Good Distribution Practice (GDP) audit is not the end of the process. It marks the start of the remediation phase that determines whether findings are closed superficially or used to strengthen the quality system. For wholesale distributors, logistics providers …

28 September 2026 Inglasia Pharma Solutions

Quality Management System for Pharmaceutical Wholesalers: Essential Elements

Uncategorised

If you’re holding or applying for a Wholesale Dealer’s Authorisation (WDA licence), your GDP Quality Management System isn’t a folder of SOPs you keep for the inspector. It’s how your business actually decides what happens to a medicine when it’s under your control.…

22 September 2026 Inglasia Pharma Solutions

CAPA Effectiveness After a GMP Audit: From Root Cause to Closure

GMP Auditing, Publication

Getting a GMP audit finding closed on paper is not the same as fixing the problem it describes. That gap is where most CAPA processes fail. That fix is your CAPA. Too often it gets treated as admin: update a document, run a retraining session, close the line in the tracker. Without real eviden…

10 September 2026 Inglasia Pharma Solutions

Computer System Validation: Pharma Requirements & EU GMP Annex 11

GMP Auditing

Many pharma firms use software to make or store GMP data. For example, LIMS, QMS, eBMR, or ERP. Once software supports GMP, you must prove it fits its purpose. You must also control risks. You must keep it under control for its whole life. This work is called Computer System Validation, or CSV. T…

24 August 2026 Inglasia Pharma Solutions

Why GMP and GDP Audits Matter for Pharmaceutical Quality and Patient Safety

GDP Auditing, GMP Auditing

Introduction GMP and GDP audits help protect medicine quality and patient safety. Quality control does not end at the factory gate. After manufacture, medicines must stay safe during storage, transport and delivery. Written procedures are important. Yet having them on paper does not prove …

13 August 2026 Inglasia Pharma Solutions

How Supplier Audits Strengthen GMP Compliance Across Your Supply Chain

GMP Auditing

Your Compliance Extends Beyond Your Walls A pharmaceutical manufacturer’s regulatory responsibility does not end at the boundary of its own facility. Under Good Manufacturing Practice regulations across all major jurisdictions, the organisation that holds the manufacturing authorisation …

31 May 2026 jose

NEWS & RESOURCES

What Happens After a GDP Audit? Managing Findings, CAPA and Remediation

Quality Management System for Pharmaceutical Wholesalers: Essential Elements

CAPA Effectiveness After a GMP Audit: From Root Cause to Closure

Computer System Validation: Pharma Requirements & EU GMP Annex 11

Why GMP and GDP Audits Matter for Pharmaceutical Quality and Patient Safety

How Supplier Audits Strengthen GMP Compliance Across Your Supply Chain

Quality assurance agency

NEWS & RESOURCES

We are committed to sharing best practice in Pharmaceutical and Biotechnology Quality Assurance and Regulation.

Quality assurance agency